Name: Exenatide acetate
Price: Inquiry

- Overview
  - Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Ligands of GPCRs
    
    Alternative Name
    
    Exendin-4
    
    CAS Number
    
    141732-76-5
    
    Molecular Formula
    
    C184H282N50O60S·C2H4O2
    
    MDL Number
    
    MFCD08704781
    
    Note
    
    There is no hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Pugazhenthi et al (2010). Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients. Diabetologia, 53(11):2357-68.
    Komsuoglu Celikyurt et al (2014). Exenatide Treatment Exerts Anxiolytic- and Antidepressant-Like Effects and Reverses Neuropathy in a Mouse Model of Type-2 Diabetes. Medical Science Monitor Basic Research, 20:112–117.
    Li et al (2010). A novel GLP-1 analog, BPI3006, with potent DPP IV resistance and good glucoregulatory effect. Biochemical and Biophtsical Research Communications, 400(4):563-8.
    Lupi et al (2008). Effects of exendin-4 on islets from type 2 diabetes patients. Diabetes Obesity and Metabolism, 10(6):515-9.
    Kim et al (2011). Mono-PEGylated Dimeric Exendin-4 as High Receptor Binding and Long-Acting Conjugates for Type 2 Anti-Diabetes Therapeutics. Bioconjugate Chemistry, 22(4):625-632.
    Davidson et al (2005). Exenatide. Nature Reviews Drug Discovery, 4:713–714.